Chicago
Case Types We Handle
Personal Injuries
Car Accidents
Truck Accidents
Motorcycle Accidents
Bicycle Accidents
Construction Accidents
Nursing Home Abuse
Wrongful Death
Slip and Fall Accidents
Daycare Injury & Abuse
Edwardsville
Case Types We Handle
Personal Injuries
Car Accidents
Truck Accidents
Motorcycle Accidents
Bicycle Accidents
Nursing Home Abuse
Wrongful Death
Slip and Fall Accidents
Daycare Injury & Abuse
Premises Liability
St. Louis
Case Types We Handle
Personal Injuries
Car Accidents
Truck Accidents
Motorcycle Accidents
Bicycle Accidents
Construction Accidents
Nursing Home Abuse
Wrongful Death
Slip and Fall Accidents
Daycare Injury & Abuse
Dangerous Drugs
Defective Products
Chemical Exposure

Ozempic Blindness and Vision Loss Lawsuit [2024 Update]

Ozempic Blindness and Vision Loss Lawsuit Overview

On this page, we’ll discuss the Ozempic Blindness and Vision Loss Lawsuit, a new study that highlighted a risk of blurred or warped vision and other sudden vision loss side effects from Ozempic, the ongoing Ozempic Lawsuit, how an Ozempic lawyer might be able to help you, and much more.

Are GLP-1 Weight Loss Drugs Linked to Vision Loss?

If you’ve experienced blurred vision or other eye problems while using Ozempic or other GLP-1 weight loss drugs, you’re not alone.

Recent research suggests semaglutide drugs may be linked to serious eye conditions, including non-arteritic anterior ischemic optic neuropathy (NAION).

NAION is a rare eye condition that occurs due to high blood pressure and problems in the blood vessels supplying the retinas and optic nerves.

This lack of blood flow can cause sudden vision loss, and it most commonly affects individuals with underlying vascular conditions, including diabetes and hypertension.

The optic nerve damage in NAION is typically irreversible, and the condition has been linked to the use of GLP-1 receptor agonists like Ozempic.

Ongoing research continues to examine the association between these drugs and an increased risk of vision problems such as blindness.

Ozempic Blindness and Vision Loss Lawsuit

If you or a loved one have developed vision loss or other serious eye injuries potentially due to Ozempic or other semaglutide drugs, you may be eligible to take legal action.

Contact TorHoerman Law for a free consultation.

You can also use the chatbot on this page to find out if you qualify for the Ozempic Lawsuit instantly.

The ongoing Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAS) Products Liability Litigation, also commonly known as the Ozempic Lawsuit, consolidates claims against drug manufacturers Novo Nordisk and Eli Lilly.

These companies produce a range of diabetes and weight loss drugs, which have been linked to severe gastrointestinal conditions such as stomach paralysis, cyclic vomiting syndrome, and bowel obstruction.

If admissible scientific evidence links Ozempic and similar drugs to vision-related injuries like NAION, these claims may also be included in the ongoing MDL, potentially expanding the scope of the lawsuits.

This would allow individuals suffering from both gastrointestinal and eye injuries to pursue legal action under the same MDL.

If you or a loved one have been affected by these injuries, it’s important to consult with an attorney to explore your legal options.

Our Ozempic Lawyers are here to help you. Contact us today.

Table of Contents

The Link Between Ozempic and Vision Problems

Recent studies have raised concerns about a potential link between Ozempic (semaglutide) and serious vision problems, particularly the rare condition known as non-arteritic anterior ischemic optic neuropathy (NAION).

This eye disorder occurs when blood flow to the optic nerve is interrupted, leading to sudden vision loss in one eye, and is often referred to as a “stroke of the optic nerve.”

According to research published by a team from Massachusetts Eye and Ear, a Harvard-affiliated hospital, patients who took Ozempic or Wegovy were found to be at a heightened risk for developing NAION.

The study revealed that those taking these semaglutide-based drugs for weight loss were seven times more likely to experience the condition than those on other obesity treatments .

While these findings are significant, the researchers emphasized that the study does not yet prove a causal link between Ozempic and NAION.

However, the association is strong enough to warrant further investigation.

The study, which analyzed six years of medical data, focused on more than 16,000 patients in the Boston area, revealing that 37 individuals across both diabetes and weight loss groups developed NAION after starting semaglutide.

In the diabetes group, patients on semaglutide had a fourfold increased risk of NAION compared to those on other treatments.

What is Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)?

Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) is a rare but serious eye condition caused by insufficient blood flow to the optic nerve.

NAION typically results in sudden, painless vision loss in one eye, often without warning.

The optic nerve, which transmits visual information from the eye to the brain, becomes damaged when its blood supply is restricted, similar to how a stroke affects the brain.

Risk factors for NAION include underlying health conditions such as diabetes, high blood pressure, and sleep apnea, which can all impact blood vessel function.

While there is no cure for NAION, early detection is critical to prevent further vision loss, as once damage occurs, it is often irreversible.

Blurry Vision and Semaglutide Drugs

Blurry vision can be linked to the use of Ozempic and other GLP-1 receptor agonist drugs, particularly due to their effects on blood sugar levels.

As these medications help control blood sugar, fluctuations in glucose levels can cause temporary changes in the shape of the eye’s lens, leading to blurred vision.

This phenomenon is especially common in older adults, as the eye’s lens becomes less flexible with age, making it more difficult for vision to stabilize during rapid blood sugar changes.

Blurred vision is a known symptom for individuals with diabetes, particularly in cases of diabetic retinopathy, where high blood sugar damages the blood vessels in the retina, potentially worsening eye health.

Ongoing Research Into Long-Term Vision Effects

The link between weight loss medications like Ozempic and vision issues is still being studied, and numerous studies are looking into the short and long-term effects Ozempic and other semaglutide drugs have on vision.

One important project is the FOCUS study.

Started in 2019, the study specifically looks into how semaglutide might affect diabetic retinopathy over time.

While this study is ongoing and results won’t be available until 2027, it’s important to stay informed and monitor your vision if you’re taking Ozempic or other GLP-1 drugs.

Ozempic and Wegovy Vision Loss Lawsuits

The ongoing Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAS) Products Liability Litigation, also known as the Ozempic MDL, has consolidated claims against manufacturers Novo Nordisk and Eli Lilly for severe gastrointestinal injuries.

As research continues to unfold, vision-related side effects, such as Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) and blurry vision, are becoming potential areas of interest in the litigation.

The July 2024 Harvard study from Massachusetts Eye and Ear found that individuals prescribed Ozempic and other GLP-1 drugs were at a heightened risk for developing NAION.

Although these findings are significant, for eye injuries like NAION or blurred vision to be included in the broader MDL, scientific evidence must be deemed admissible in court.

This process involves verifying the scientific integrity and relevance of studies linking semaglutide use to vision problems.

If these connections can be scientifically validated and pass the standards for admissibility, plaintiffs may be able to pursue compensation for vision-related injuries alongside gastrointestinal claims in the ongoing litigation.

This requires additional research and expert testimony to ensure these claims can withstand scrutiny in court, emphasizing the need for further investigations into these emerging side effects.

If you’ve suffered from NAION, vision loss, blurry vision, or other eye injuries after taking semaglutide drugs like Ozempic and Wegovy, you may be eligible to file an Ozempic Lawsuit.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to find out if you qualify for the Ozempic Lawsuit instantly.

The Rise of Lawsuits Against Ozempic, Wegovy, and Other GLP1 Drug Manufacturers

The majority of the Ozempic Lawsuits center around gastrointestinal issues that patients have suffered after taking Ozempic and similar drugs like Wegovy, Mounjaro, Trulicity, and potentially more.

These problems range from severe nausea and vomiting to more serious conditions like gastroparesis.

Gastroparesis is a disorder where the stomach’s ability to move food is slowed down or completely stopped, leading to stomach paralysis.

Patients dealing with these complications argue that they weren’t adequately warned about the risks.

Plaintiffs claim that Novo Nordisk and Eli Lilly, the makers of these drugs, failed to provide proper warnings about these potential side effects.

According to the lawsuits, the companies knew — or should have known — about these risks but did not alert the medical community or the public in time.

The FDA has acknowledged the reports but has not issued an official warning about Ozempic despite the growing number of patients complaining of gastroparesis and eye conditions.

In 2023, the FDA required the manufacturers of Ozempic and Wegovy to update the drug’s warning label to include the risk of bowel obstruction, a severe gastrointestinal side effect.

What To Do If You Suspect Vision Loss Due to Ozempic and Other Semaglutide Drugs

If you suspect that Ozempic or another semaglutide drug has affected your vision, act quickly.

Early intervention may help prevent further damage and protect your legal rights. Here are the steps you should take.

Seek Medical Attention Immediately

If you notice any changes in your vision, such as blurred vision, difficulty focusing, or sudden loss of sight, schedule an appointment with your healthcare provider right away.

Doctors can evaluate your symptoms, check for conditions like diabetic retinopathy or optic nerve damage, and help you determine whether Ozempic could be a contributing factor.

Schedule an Eye Exam

Your healthcare provider will likely recommend seeing an eye doctor or specialist for a thorough examination.

Regular eye exams are important if you’re taking medications that can potentially affect your vision or if you’re experiencing worsening symptoms.

An eye specialist can help track any changes and suggest treatment options if necessary.

Document Your Symptoms

Keep a detailed record of your vision changes, including the dates and severity of symptoms.

This documentation will be helpful for your healthcare provider and may serve as evidence in any legal action you may pursue.

Make sure to note any conversations with your doctors and test results as well.

Contact the Ozempic Lawyers at TorHoerman Law

If you suspect that Ozempic is responsible for your vision loss, it’s a good idea to consult with a lawyer experienced in pharmaceutical lawsuits.

The Ozempic Lawyers TorHoerman Law can help you understand your rights and determine whether you may be eligible to join the ongoing Ozempic Lawsuit.

TorHoerman Law: Ozempic Attorneys

Vision loss and other eye-related side effects from Ozempic are serious concerns that require immediate attention.

If you’re experiencing symptoms like blurred vision or more severe eye problems, take action quickly by consulting with your healthcare provider and scheduling an eye exam.

Protecting your health is the first priority.

Our Ozempic Lawyers are keeping tabs on the possible risk of serious eye injuries and vision loss in relation to Ozempic use.

Contact us for a free consultation.

You can also use the chatbot on this page to find out if you’re eligible for an Ozempic Lawsuit.

Frequently Asked Questions

  • Is Ozempic Linked to Blindness and Vision Loss?

    Researchers at Massachusetts Eye and Ear, a Harvard-associated specialty hospital in Boston, found that individuals who took Ozempic were at a significantly higher risk of developing Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION), a condition that can lead to sudden vision loss.

    According to Mass. Eye and Ear, patients taking Ozempic for weight loss had a seven times higher likelihood of developing this condition compared to those on other obesity medications.

    The study noted that while this association is concerning, more research is needed to confirm a direct link between semaglutide and vision problems.

    Patients with pre-existing risk factors, such as diabetes or heart disease, may already have an elevated risk of NAION, making it difficult to determine the drug’s direct role.

    If scientific evidence supporting these findings is deemed admissible in court, eye injuries may be included in the ongoing Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAS) Products Liability Litigation.

  • What are the Symptoms of Ozempic Vision Loss?

    Ozempic, a drug primarily used to treat type 2 diabetes and lose weight, has been linked to certain vision problems, particularly Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION).

    The symptoms of vision loss from Ozempic can include:

    • Blurred vision: A sudden inability to see clearly.
    • Loss of peripheral vision: A reduction in the ability to see things outside the direct line of sight.
    • A dark or gray spot in your vision that doesn’t move.
    • Loss of contrast or light sensitivity, making it harder to differentiate between objects in dim light.
    • Distortion of colors: Colors may appear washed out or look different than usual.

    If these symptoms occur, it is crucial to stop using the medication immediately and seek medical attention, as vision loss from NAION is often permanent.

  • What are Other Health Risk Linked to Ozempic?

    In addition to vision problems, Ozempic has been associated with several other serious health risks.

    Some of the most notable include:

    • Gastrointestinal issues: Patients have reported gastroparesis (stomach paralysis), bowel obstruction, and severe abdominal pain.
    • Cyclic vomiting syndrome (CVS): This condition involves recurrent episodes of vomiting that can last for days.
    • Pancreatitis: Inflammation of the pancreas, which can lead to life-threatening complications.
    • Kidney injury: Reports of acute kidney damage due to dehydration from ongoing vomiting or other complications.
    • Increased risk of gallbladder disease, including gallstones, which can cause severe abdominal pain and may require surgery.

    These risks are the basis for many Ozempic Lawsuits currently being filed, as patients argue that they were not adequately warned about these adverse health effects.

  • Who Can File an Ozempic Lawsuit?

    Individuals who have suffered severe side effects from taking Ozempic may be eligible to file a lawsuit.

    Those who may qualify for the Ozempic Lawsuit include:

    • Patients who experienced gastrointestinal issues, such as gastroparesis, cyclic vomiting syndrome, or bowel obstruction after using Ozempic or other GLP-1 receptor agonist drugs.
    • People who have developed vision problems or blindness, particularly NAION, after taking the drug.
    • Individuals who have suffered from pancreatitis, gallbladder issues, or kidney injuries potentially linked to the drug.
    • Those who can demonstrate that they were not provided with adequate warnings regarding these serious health risks when they were prescribed Ozempic.

    If you or a loved one has experienced these side effects, you may be eligible to join the Ozempic Lawsuit.

    It is advisable to consult with an Ozempic Lawyer to discuss your case and explore your legal options.

Written By:
Tor Hoerman

Tor Hoerman

Owner & Attorney - TorHoerman Law

Do You
Have A Case?

Here, at TorHoerman Law, we’re committed to helping victims get the justice they deserve.

Since 2009, we have successfully collected over $4 Billion in verdicts and settlements on behalf of injured individuals.

Would you like our help?

About TorHoerman Law

At TorHoerman Law, we believe that if we continue to focus on the people that we represent, and continue to be true to the people that we are – justice will always be served.

Do you believe you’re entitled to compensation?

Use our Instant Case Evaluator to find out in as little as 60 seconds!

$495 Million
Baby Formula NEC Lawsuit

In this case, we obtained a verdict of $495 Million for our client’s child who was diagnosed with Necrotizing Enterocolitis after consuming baby formula manufactured by Abbott Laboratories.

$20 Million
Toxic Tort Injury

In this case, we were able to successfully recover $20 Million for our client after they suffered a Toxic Tort Injury due to chemical exposure.

$103.8 Million
COX-2 Inhibitors Injury

In this case, we were able to successfully recover $103.8 Million for our client after they suffered a COX-2 Inhibitors Injury.

$4 Million
Traumatic Brain Injury

In this case, we were able to successfully recover $4 Million for our client after they suffered a Traumatic Brain Injury while at daycare.

$2.8 Million
Defective Heart Device

In this case, we were able to successfully recover $2.8 Million for our client after they suffered an injury due to a Defective Heart Device.

Guides & Resources
Do You
Have A Case?

Here, at TorHoerman Law, we’re committed to helping victims get the justice they deserve.

Since 2009, we have successfully collected over $4 Billion in verdicts and settlements on behalf of injured individuals.

Would you like our help?

You can learn more about the Ozempic Lawsuit by visiting any of our pages listed below:

All
FAQs
Injuries & Conditions
Legal Help
Settlements & Compensation
Other Resources

Share

Related Posts

What Our Clients Have To Say